Inadequate antibiotic treatment for infections has negative consequences in terms of morbidity and even mortality. On top of that, inadequate antibiotic treatment could lead to the development of multi-drug resistant microorganisms. Regular assessment of the characteristics of infections, including susceptibility patterns, leads to optimisation of antibiotic treatment selection.
A study presented by Dr José Medina-Polo (Hospital Universitario 12 de Octubre, Madrid, Spain) analysed the evolution of antibiotic prescription in patients with healthcare-associated infections who were hospitalised in their urology department from 2012 to 2020. Between 2012 and 2015, the most frequently used antibiotics were third and fourth generation cephalosporins (36.9–48.2%). From 2016 onwards, carbapenems were most frequently prescribed (41.5–51.1%).
Due to the updated protocol for empirical treatment in 2020, the prescription of carbapenems decreased to 28.6% and the prescription of third and fourth generation cephalosporins became 42.9%. From 2012 to 2020, the empirical prescription of quinolones decreased from 6.4% to 1.8%.
During the study period, it was increasingly common to change antibiotics in case an antibiogram (i.e. the antibiotic resistance patterns) was available, aimed to reduce the antibiotic spectrum. Once the antibiogram was available, cephalosporins were more frequently prescribed (55.2%) than carbapenems (12.5%).
These results demonstrated that it is essential to review the antibiogram to select the most appropriate antibiotic and try to reduce the spectrum; thereby minimising the occurrence of multi-drug resistant microorganisms.
- Medina-Polo J. Evaluation of the evolution of antibiotic prescription in the treatment of Healthcare-Associated Infections (HAIs) in a urology ward after implementing a treatment optimisation programme. P0163, EAU21 Virtual, 8–12 July 2021.
Copyright ©2021 Medicom Medical Publishers
Posted on
Previous Article
« Best of EAU: The surgical armamentarium is evolving Next Article
Failure of conservative management in emphysematous pyelonephritis »
« Best of EAU: The surgical armamentarium is evolving Next Article
Failure of conservative management in emphysematous pyelonephritis »
Table of Contents: EAU 2021
Featured articles
EAU TV: Robotic surgery and advanced prostate cancer
LUTS & BPH
Best of EAU: The surgical armamentarium is evolving
IPSS: Visual alternatives to aid comprehension and new risk prediction models
Urinary Tract Infections
Prophylactic treatments for recurrent urinary tract infections
Failure of conservative management in emphysematous pyelonephritis
Antibiotic treatment of healthcare-associated infections
Prostate Cancer
EAU TV: Robotic surgery and advanced prostate cancer
EAU TV: The best on prostate cancer and incontinence & andrology
Best of EAU: Updates on imaging and treatment of prostate cancer
Radiographic PFS benefit of adding abiraterone to ADT and docetaxel in mCSPC
177Lu-PSMA-617: A new class of effective therapy
Testis and Penile Cancer
Best of EAU: New advances in testicular and penile cancer
Recommendations for the management of indeterminate small testis masses
Residual tumour resection in case of elevated markers
Bladder Cancer
Best of EAU: Highlights on bladder cancer
ctDNA can guide adjuvant immunotherapy in muscle-invasive bladder cancer
Durvalumab ± tremelimumab by cisplatin eligibility in metastatic urothelial carcinoma
Circulating tumour cells could aid in the decision to give neoadjuvant chemotherapy
Renal Cancer
Best of EAU: Immune cell populations have prognostic value in RCC
KEYNOTE-564: First positive phase 3 results with adjuvant checkpoint inhibition in RCC
PSMA PET-CT more accurate than standard-of-care imaging in RCC
Worse renal function after radical versus partial nephrectomy
Related Articles
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com